Insights & events

2022 Sun Life Stop-Loss Research Report: High-cost claims and injectable drug trends analysis

For the past ten years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims. 

2022 Sun Life Stop-Loss Research Report: High-cost claims and injectable drug trends analysis

For the past ten years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims. 

  • February 28, 2024

    2024 Updates and 2023 Year in Review on Leave and Accommodations Webinar

    Watch Marjory Robertson, AVP & Senior Counsel, Sun Life and Abigail O’Connell, Senior Counsel, Sun Life, for  a recap of 2023 legal and compliance developments related to leave and accommodation law. They also provided updates on the federal Pregnancy Workers Fairness Act, and other compliance issues trending in 2024. 

  • September 20, 2023

    2023 Updates on Leave and Accommodation laws

    Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments. 

    They also include a section on recent jury verdicts involving the FMLA and the ADA, which is always an audience favorite.

  • May 17, 2023

    2023 High-cost claims and injectable drug trends analysis

    For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims. While a lot has changed over the eleven years, one thing has not: our commitment to providing you with actionable insights that can help you stay informed about conditions and medications most likely to result in a high-cost claim, and steps you can take to manage that risk as a self-funded employer. 

    Join our team of experts dive deeper into our key insights and provide actionable recommendations for employers.

  • February 08, 2023

    2023 Future Forecast with Jennifer Collier and James Slotnick

    What's top of mind for Sun Life leaders? Sun Life's SVP of Health and Risk Solutions, Jennifer Collier and James Slotnick, Head of Government Relations share their perspectives on the evolving industry landscape in this 2023 Future Forecast.

  • February 06, 2023

    Introduction to Gene Therapies (3rd edition)

    Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.

  • September 29, 2022

    Impacts of Blood Cancer: Blood Cancer was the #2 high-cost claims condition and nearly 10% of 2021 total spend within Sun Life’s Health & Risk Solutions book of business

    Every three minutes, someone in the U.S. is diagnosed with blood cancer. In our new Bright Paper, Sun Life shares research data and expert insights to help employers manage the impact of these high-cost claims, some of which can reach millions of dollars for treatment for a single patient, and get the best care for members.

  • June 22, 2022

    2022 Sun Life Stop-Loss Research Report: High-cost claims and injectable drug trends analysis

    For the past ten years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims. While a lot has changed over the past decade, one thing has not: our commitment to providing you with actionable insights that can help you stay informed about conditions and medications most likely to result in a high-cost claim, and steps you can take to manage that risk as a self-funded employer.

  • June 08, 2022

    2022 High-cost claims and injectable drug trends analysis

    A presentation and panel discussion on our high-cost claims and injectable drug trends analysis with insights on top claim conditions, million-dollar claims, injectable drugs, and trends we are seeing since the COVID-19 pandemic began.

  • June 08, 2021

    2021 High-cost claims and injectable drug trends analysis

    A presentation and panel discussion on our annual Stop-Loss high-cost claims and injectable drugs trends analysis, the impact of COVID-19, million-dollar claims and more!

    Webinar: Slide deck

  • May 24, 2021

    Group stop-loss captives: A path to self-funding

    Learn about the rising interest in self-funding and how employers of many sizes can transition to self-funding with group stop-loss captives, including different captive options and structures.